REFRACTORY COLORECTAL CARCINOMA
Clinical trials for REFRACTORY COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug duo targets Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a new drug called M6620 (berzosertib) combined with the chemotherapy irinotecan in people with advanced solid tumors that have spread or can't be removed. The goal is to find the safest dose and see if the combination can slow tumor growth. About 66 p…
Matched conditions: REFRACTORY COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
Blood test may help tailor cancer therapy for advanced colorectal cancer patients
Disease control OngoingThis study explores whether a blood test that detects tumor DNA (ctDNA) can help doctors choose the right treatment for people with advanced colorectal cancer that has not responded to prior therapies. About 100 participants will receive either standard treatment or treatment gui…
Matched conditions: REFRACTORY COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC